eMedevents
  • 124798+ Medical Conferences
  • 251 Specialties
  • 31847 Organizers
  • 144480 Speakers
  • 154 Countries
  • 4295 Cities
41599+
CME Conference Registrations Sold
Home  >  Speakers  >  Michal Bassani-sternberg
Michal Bassani-sternberg

Michal Bassani-sternberg

    PhD
Director | Epalinges, Vaud    Switzerland
Oncology, Immunology And Microbiology
Oncology, Immunology And Microbiology,...More
Spoken at 2 events
Speaking at 1 event

Biography :

Michal Bassani-Sternberg is heading the Immunopeptidomics unit that is integrated within the Center of Experimental Therapeutic (CTE) in the department of Oncology at the CHUV, Lausanne, Switzerland, where she integrates mass spectrometry based immunopeptidomics into the innovative translational clinical strategy of personalized immunotherapy. In the last ten years, Dr Bassani-Sternberg has focused her research mainly on the development of methodologies for highly accurate and in-depth immunopeptidomics. She has completed her PhD at the Faculty of Biology at the Technion - Israel Institute of Technology and post-doctorate at the Proteomics and Signal Transduction Department, headed by Prof. Matthias Mann at the Max Planck Institute of Biochemistry. Recently she has integrated next generation sequencing with immunopeptidomics to directly identify patient’s specific neo-epitopes presented on melanoma tissues.

**********************
*** ** *** ** **
 
For speaker's contact information - Contact us

Specialties

Oncology, Immunology and Microbiology

Interested Topics

Oncology, Immunology and Microbiology, Human Leukocyte Antigen, Mass Spectrometry, Biochemistry, Proteomics, Cell Culture, Molecular Biology, Research, Cell Biology, Immunology, Protein Chemistry, Science, Biomarkers, Immunopeptidomics

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English, Hebrew

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message